- Presentations
- 2
- Markets
- 1
Daliresp is a brand of Roflumilast marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Roflumilast
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 250 mcg tablet, 500 mcg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Daliresp 250 mcg tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Daliresp 500 mcg tabletOral | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Roflumilast.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Daliresp
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.